Opioid Crisis
-
Experimental vaccine shields mice from fentanyl and its chemical relatives
WASHINGTON — Inside a laboratory, a small group of mice is changing how researchers think about the opioid crisis. These animals, immunized…
-
Scripps Chemist Develops Vaccine To Train Immune System Against Fentanyl
LA JOLLA — Dr. Kim D. Janda is working on a vaccine that could change how the country fights the fentanyl crisis.…
-
Fentanyl Vaccine That Keeps the Drug Out of the Brain Is Set for Human Trials
ISLAMABAD, July 13 — A vaccine candidate designed to block fentanyl from reaching the brain has completed preclinical studies in animals, with…
-
Synthetic opioid deaths rose more than 23-fold from 2013 to 2023 before a 2024 drop
WASHINGTON, July 13 — The opioid crisis in the United States has reached unprecedented levels, with the Centers for Disease Control and…
-
Overdose deaths hit record high in 2021, fentanyl drives surge
WASHINGTON, July 13 — The opioid crisis in the United States has escalated dramatically over the past two decades, with synthetic opioids…
-
University of Houston Fentanyl Vaccine Targets Drug’s Chemical Backbone
HOUSTON, July 13 — A novel vaccine candidate developed at the University of Houston is targeting the chemical backbone of fentanyl and…
-
Experimental vaccine protects mice against fentanyl and related opioids in new study
HOUSTON, July 13 — On the ground in the fight against the opioid crisis, researchers at the University of Houston and the…
-
FDA Approves Vertex’s Journavx, the First New Class of Pain Medicine in Over 20 Years
Vertex Pharmaceuticals is awaiting a regulatory decision on suzetrigine, a non-opioid analgesic designed for moderate to severe acute pain. The drug, which…
-
Journavx, a Non-Opioid Painkiller, Remains Out of Reach for Many Pain Patients
As of January 28, 2025, a novel oral medication for moderate to severe acute pain is approaching clinical availability. Suzetrigine, to be…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992









